Sutab ® (sodium sulfate, magnesium sulfate, and potassium chloride tablets; Sebela Pharmaceuticals), an osmotic laxative, is now available for cleansing of the colon in preparation for ...

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced ...

You can also take potassium chloride through an extended-release tablet, extended-release capsule, injectable, oral solution, and powder for oral solution. Before you start or stop taking the ...

Results. In line with the USP Monograph titled “Potassium Bicarbonate and Potassium Chloride Effervescent Tablets for Oral Solution,” the IC assay for chloride content was validated. 2 The chloride ...

Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.

Glenmark Laboratories recalled 114 batches of 750 mg Potassium Chloride Extended-Release Capsules in bottles of 100 (NDC No. 68462-357-01) and 500 (NDC No. 68462-357-05) capsules.

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10mEq (750 mg) and 20mEq ...

The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by Merck Sharp & Dohm, a subsidiary of Kenilworth, N.J.-based Merck. The K Dur tablets reported ...

Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used for treating low levels of potassium in blood. “Glenmark ...

Company's current portfolio consists of 117 products authorised for distribution in the US marketplace and 61 ANDA pending approval with the USFDA.

Citing IQVIA Health data, Granules said Potassium Chloride extended release tablets had US generic sales of approximately USD 204 million for the most recent 12 months ending in August 2020.